Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Abstract Background The efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer has been demonstrated in phase III trials. However, as patients receiving eribulin in daily practice do not necessarily meet all the eligibility criteria of clinical trials, data for...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sakura Iizumi, Tatsunori Shimoi, Natsuko Tsushita, Seiko Bun, Akihiko Shimomura, Emi Noguchi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2017-12-01
Serie:	BMC Cancer
Soggetti:	Breast cancer Eribulin Efficacy Safety
Accesso online:	http://link.springer.com/article/10.1186/s12885-017-3846-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!